• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部进展期胰腺腺癌的放射治疗——随机试验的批判性评价。

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma-A Critical Review of Randomised Trials.

机构信息

Department of Oncology, Odense University Hospital, 5000 Odense, Denmark.

Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.

出版信息

Curr Oncol. 2023 Jul 18;30(7):6820-6837. doi: 10.3390/curroncol30070499.

DOI:10.3390/curroncol30070499
PMID:37504359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378124/
Abstract

Pancreatic cancer is rising as one of the leading causes of cancer-related death worldwide. Patients often present with advanced disease, limiting curative treatment options and therefore making management of the disease difficult. Systemic chemotherapy has been an established part of the standard treatment in patients with both locally advanced and metastatic pancreatic cancer. In contrast, the use of radiotherapy has no clear defined role in the treatment of these patients. With the evolving imaging and radiation techniques, radiation could become a plausible intervention. In this review, we give an overview over the available data regarding radiotherapy, chemoradiation, and stereotactic body radiation therapy. We performed a systematic search of Embase and the PubMed database, focusing on studies involving locally advanced pancreatic cancer (or non-resectable pancreatic cancer) and radiotherapy without any limitation for the time of publication. We included randomised controlled trials involving patients with locally advanced pancreatic cancer, including radiotherapy, chemoradiation, or stereotactic body radiation therapy. The included articles represented mainly small patient groups and had a high heterogeneity regarding radiation delivery and modality. This review presents conflicting results concerning the addition of radiation and modality in the treatment regimen. Further research is needed to improve outcomes and define the role of radiation therapy in pancreatic cancer.

摘要

胰腺癌是全球导致癌症相关死亡的主要原因之一。患者通常表现为晚期疾病,限制了根治性治疗选择,因此使疾病的治疗变得困难。全身化疗一直是局部晚期和转移性胰腺癌患者标准治疗的重要组成部分。相比之下,放射治疗在这些患者的治疗中没有明确的作用。随着影像学和放射技术的不断发展,放射治疗可能成为一种可行的干预手段。在这篇综述中,我们概述了关于放射治疗、放化疗和立体定向体部放射治疗的现有数据。我们在 Embase 和 PubMed 数据库中进行了系统搜索,重点是涉及局部晚期胰腺癌(或不可切除的胰腺癌)和无时间限制的放射治疗的研究。我们纳入了涉及局部晚期胰腺癌患者的随机对照试验,包括放射治疗、放化疗或立体定向体部放射治疗。纳入的文章主要是小患者组,在放射治疗的提供和方式方面存在很大的异质性。本综述对于添加放射治疗和治疗方案中的治疗方式呈现出相互矛盾的结果。需要进一步的研究来改善结果并确定放射治疗在胰腺癌中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10378124/3360a8abaf3d/curroncol-30-00499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10378124/3360a8abaf3d/curroncol-30-00499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10378124/3360a8abaf3d/curroncol-30-00499-g001.jpg

相似文献

1
Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma-A Critical Review of Randomised Trials.局部进展期胰腺腺癌的放射治疗——随机试验的批判性评价。
Curr Oncol. 2023 Jul 18;30(7):6820-6837. doi: 10.3390/curroncol30070499.
2
Radiation therapy in the management of pancreatic adenocarcinoma: review of current evidence and future opportunities.放射治疗在胰腺腺癌治疗中的应用:当前证据综述与未来机遇
Chin Clin Oncol. 2017 Jun;6(3):28. doi: 10.21037/cco.2017.06.12.
3
[The value of chemoradiotherapy in the management of locally advanced pancreatic adenocarcinoma: systematic review].[放化疗在局部晚期胰腺癌治疗中的价值:系统评价]
Bull Cancer. 2008 Nov;95(11):1116-30. doi: 10.1684/bdc.2008.0749.
4
Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy.胰脏交界可切除和局部进展期胰脏癌切除术后并发症:新辅助化疗联合常规放疗或立体定向体部放疗的影响。
Surgery. 2018 May;163(5):1090-1096. doi: 10.1016/j.surg.2017.11.027. Epub 2018 Mar 12.
5
Radiotherapy for locally advanced pancreatic ductal adenocarcinoma.局部晚期胰腺导管腺癌的放射治疗
Semin Oncol. 2021 Feb;48(1):106-110. doi: 10.1053/j.seminoncol.2021.02.005. Epub 2021 Feb 23.
6
Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.局部进展期胰腺癌放射治疗技术考虑:美法共识推荐。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1355-64. doi: 10.1016/j.ijrobp.2011.11.050.
7
Treatment of locally advanced pancreatic cancer: the role of radiation therapy.局部晚期胰腺癌的治疗:放射治疗的作用。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):508-18. doi: 10.1016/j.ijrobp.2011.08.008. Epub 2011 Nov 9.
8
Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma.局部晚期胰腺腺癌的治疗方法
Hematol Oncol Clin North Am. 2015 Aug;29(4):741-59. doi: 10.1016/j.hoc.2015.04.005. Epub 2015 May 30.
9
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
10
Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.立体定向体部放射治疗能否成为不可切除的局部晚期胰腺腺癌可行且有效的治疗选择?一项2期研究的结果
Technol Cancer Res Treat. 2017 Jun;16(3):295-301. doi: 10.1177/1533034616650778. Epub 2016 Jun 16.

引用本文的文献

1
Prediction of overall survival in patients with locally advanced pancreatic cancer using longitudinal diffusion-weighted MRI.利用纵向扩散加权磁共振成像预测局部晚期胰腺癌患者的总生存期
Front Oncol. 2024 Jul 18;14:1401464. doi: 10.3389/fonc.2024.1401464. eCollection 2024.
2
New Frontiers in Pancreatic Cancer Management: Current Treatment Options and the Emerging Role of Neoadjuvant Therapy.胰腺癌管理的新前沿:当前治疗选择和新辅助治疗的新兴作用。
Medicina (Kaunas). 2024 Jun 28;60(7):1070. doi: 10.3390/medicina60071070.
3
Variation in outcomes and practice patterns among patients with localized pancreatic cancer: the impact of the pancreatic cancer multidisciplinary clinic.

本文引用的文献

1
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).一项改良 FOLFIRINOX 对比吉西他滨联合 nab-紫杉醇治疗局部进展期胰腺癌的随机 II 期研究(JCOG1407)。
Eur J Cancer. 2023 Mar;181:135-144. doi: 10.1016/j.ejca.2022.12.014. Epub 2022 Dec 27.
2
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study.立体定向磁共振引导下的胰腺癌自适应放疗:蒙彼利埃前瞻性注册研究的更新结果。
Cancers (Basel). 2022 Dec 20;15(1):7. doi: 10.3390/cancers15010007.
3
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
局部胰腺癌患者的治疗结果和实践模式差异:胰腺癌多学科诊疗门诊的影响
Front Oncol. 2024 Jul 11;14:1427775. doi: 10.3389/fonc.2024.1427775. eCollection 2024.
4
The preclinical gap in pancreatic cancer and radiotherapy.胰腺癌和放疗的临床前差距。
Dis Model Mech. 2024 Jul 1;17(7). doi: 10.1242/dmm.050703. Epub 2024 Jul 9.
5
Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy.新辅助化疗后联合或不联合放疗行辅助化疗治疗切除术后的胰腺癌:多药物新辅助化疗后的随机临床试验 **解析**:原文“Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy.”中,“adjuvant chemotherapy”译为“辅助化疗”;“radiotherapy”译为“放疗”;“neoadjuvant chemotherapy”译为“新辅助化疗”。
Ann Surg Oncol. 2024 Aug;31(8):4966-4975. doi: 10.1245/s10434-024-15157-4. Epub 2024 May 24.
6
New avenues for the treatment of immunotherapy-resistant pancreatic cancer.治疗免疫疗法耐药性胰腺癌的新途径。
World J Gastrointest Oncol. 2024 Apr 15;16(4):1134-1153. doi: 10.4251/wjgo.v16.i4.1134.
在可切除边缘的胰腺癌患者中,即刻手术与短程新辅助吉西他滨联合卡培他滨、FOLFIRINOX或放化疗的比较(ESPAC5):一项四臂、多中心、随机、2期试验
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):157-168. doi: 10.1016/S2468-1253(22)00348-X. Epub 2022 Dec 12.
4
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation.等毒性高剂量立体定向体部放疗(iHD-SBRT)与传统放化疗治疗局部胰腺癌的单癌症中心评估
Cancers (Basel). 2022 Nov 22;14(23):5730. doi: 10.3390/cancers14235730.
5
Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial.新辅助mFOLFIRINOX方案与mFOLFIRINOX方案联合放疗用于可切除边缘胰腺癌患者的疗效比较——A021501试验
JAMA Oncol. 2023 Feb 1;9(2):276-277. doi: 10.1001/jamaoncol.2022.6141.
6
Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system.在1.5特斯拉磁共振直线加速器系统上对胰腺癌进行立体定向消融放疗。
Phys Imaging Radiat Oncol. 2022 Oct 28;24:88-94. doi: 10.1016/j.phro.2022.10.003. eCollection 2022 Oct.
7
Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.新辅助治疗与直接手术治疗对可切除边缘胰腺癌的肿瘤学益处:一项系统评价与荟萃分析
Cancers (Basel). 2022 Sep 7;14(18):4360. doi: 10.3390/cancers14184360.
8
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.术前 mFOLFIRINOX 对比 mFOLFIRINOX 联合短程放疗治疗边界可切除胰腺腺癌的疗效:A021501 期随机临床试验。
JAMA Oncol. 2022 Sep 1;8(9):1263-1270. doi: 10.1001/jamaoncol.2022.2319.
9
Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials.新辅助化疗联合或不联合放疗与直接手术治疗可切除胰腺腺癌的比较:一项随机临床试验的荟萃分析。
ESMO Open. 2022 Jun;7(3):100485. doi: 10.1016/j.esmoop.2022.100485. Epub 2022 May 14.
10
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study.立体定向磁共振引导下的胰腺癌放疗:前瞻性注册研究中自适应放疗的剂量学优势及初步临床结果
Front Oncol. 2022 Mar 9;12:842402. doi: 10.3389/fonc.2022.842402. eCollection 2022.